Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BDR International Pvt. Ltd.

Latest From BDR International Pvt. Ltd.

Eisai Seeks To Block Dr Reddy’s Over Belviq Plans In India

Eisai has moved court against Dr Reddy’s for alleged infringement of its patent on Belviq in India. The case is expected to put the spotlight back on prickly IPR issues, including working of patents.

Intellectual Property Legal Issues

Lee v AstraZeneca: India’s Next David And Goliath Fight?

A 40% chance for success and mere "publicity stunt" are some of the sharp early reactions to the surprise compulsory license application in India for AstraZeneca's saxagliptin by Hyderabad-based Lee Pharma, though the little known firm appears confident that its arguments in favor of a license hold water.

BioPharmaceutical India

Lee Takes India Compulsory License Fight To Saxagliptin

In a bold move, little known Indian drug firm Lee Pharma has applied for a compulsory license for saxagliptin in India, contending that AstraZeneca sells the diabetes drug at an exorbitant local price and that it is not being made sufficiently available. Lee also says that the originator has not responded to calls to collaborate.

BioPharmaceutical Asia Pacific

As Cipla, Novartis Cross Onbrez Swords, Others May Jump In

After a brief lull, patent-related tussles are back in the Indian pharmaceutical industry. Cipla’s recent submission to the Indian government to review Novartis’ Onbrez patent may potentially prompt smaller drug makers to follow the same path and gain authorization to launch their own variants of patented brands.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • BDR International Pvt. Ltd.
  • Senior Management
  • Dharmesh Shah, Chmn. & Managing Dir.
  • Contact Info
  • BDR International Pvt. Ltd.
    Phone: 22 40560560
    407/408 Sharda Chambers
    15 New Marine
    Mumbai, 400020